Table 3:

Revised criteria for assessment of remission in MDS according to an international working group [180].

Criteria	Response
Morphologic and Hematologic	Complete Remission (CR): bone marrow blasts <5% without dysplasia, hemoglobin ≥11 g/dL, platelets ≥100 × 109/L, neutrophils ≥1.5 × 109/L. Partial Remission (PR): reduction of blasts by at least 50% or achievement of lower risk category than prior to treatment.
Cytogenetic	Major Cytogenetic Response: disappearance of a cytogenetic abnormality. Minor Cytogenetic Response: ≥50% reduction of abnormal metaphases.